Source link : https://www.newshealth.biz/health-news/inflammation-now-the-key-target-for-seborrheic-dermatitis/
NEW YORK — Topical antifungals should no longer be considered a first-line therapy for seborrheic dermatitis for two reasons: Topical anti-inflammatories have replaced them, and rates of drug-resistant fungal infections are rising, according to an update on this skin disease. Now that there is compelling evidence that seborrheic dermatitis is best characterized as an inflammatory […]
Author : News Health
Publish date : 2025-01-06 05:48:09
Copyright for syndicated content belongs to the linked Source.